Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
4 trials match this view; 10 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 216 across 4 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsAlcohol Use Disorder · Depressive Sympotoms · Psilocybin | Centre Hospitalier Universitaire de Nīmes PHASE3 | Recruiting Registry updated 2026-07-01 | 172 ESTIMATED | 2026-06-30 2030-06 2030-06 | |
| Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic SeizuresPsychogenic Nonepileptic Seizures · Psilocybin | Centre Hospitalier Universitaire de Nīmes NA | Completed Registry updated 2025-08-21 | 4 ACTUAL | 2024-12-19 2025-01-03 2025-05-22 | |
| Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyDepressive Disorder · Depressive Disorder, Treatment-Resistant · Hallucinogens · Reinforcement, Psychology | Centre Hospitalier Universitaire de Nīmes NA | Completed Registry updated 2025-08-20 | 10 ACTUAL | 2024-11-19 2025-03-26 2025-06-26 | |
| Psilocybin in Alcohol Use Disorder With Comorbid DepressionAlcohol-Related Disorders · Depressive Disorder · Addiction | Centre Hospitalier Universitaire de Nīmes NA | Completed Registry updated 2025-03-19 | 30 ACTUAL | 2024-02-05 2024-11-19 2025-01-09 |
Reported research facilities
Centre Hospitalier de la Côte BasqueBayonne, France
CHU BesançonBesançon, France
CHU de BordeauxBordeaux, France
CHU BrestBrest, France
CH Le VinatierBron, France
CHU de NantesNantes, France
CHU de NîmesNîmes, France
CHU Saint-EtienneSaint-Priest, France
CHU de Nîmes, Hôpital Universitaire CarémeauNîmes, France
CHUNîmes, Nîmes, France
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.